William McKee joined C4 Therapeutics in April 2020 as our interim Chief Financial Officer. William currently serves as Chief Executive Officer of MBJC Associates, LLC, a business consulting firm serving the pharmaceutical and biotech industry. Previously, he served as Chief Operating Officer and Chief Financial Officer for EKR Therapeutics, Inc., or EKR, from July 2010 until June 2012 when EKR was sold to Cornerstone Therapeutics Inc. Prior to EKR, he served as the Executive Vice President, Chief Financial Officer and Treasurer of Barr Pharmaceuticals, LLC, a subsidiary of Teva Pharmaceutical Industries Limited. William was also Executive Vice President and Chief Financial Officer of Barr, prior to its acquisition by Teva. He currently serves on the boards of Assertio Therapeutics, Inc. (formerly known as Depomed, Inc.) and Aileron Therapeutics, Inc. He was a director at Cerulean Pharma Inc., until it was acquired by Daré Bioscience Operations, Inc. in July 2017, and Auxilium Pharmaceuticals, Inc. until it was acquired by Endo International plc in January 2015. William received his Bachelor of Business Administration degree from the University of Notre Dame.